Literature DB >> 16920819

Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines.

Isabel A Hutchings1, Rosemary J Tierney, Gemma L Kelly, Julianna Stylianou, Alan B Rickinson, Andrew I Bell.   

Abstract

The Epstein-Barr virus (EBV) latent cycle promoter Wp, present in each tandemly arrayed copy of the BamHI W region in the EBV genome, drives expression of the EB viral nuclear antigens (EBNAs) at the initiation of virus-induced B-cell transformation. Thereafter, an alternative EBNA promoter, Cp, becomes dominant, Wp activity declines dramatically, and bisulfite sequencing of EBV-transformed lymphoblastoid cell lines (LCLs) shows extensive Wp methylation. Despite this, Wp is never completely silenced in LCLs. Here, using a combination of bisulfite sequencing and methylation-specific PCR, we show that in standard LCLs transformed with wild-type EBV isolates, some Wp copies always remain unmethylated, and in LCLs transformed with a recombinant EBV carrying just two BamHI W copies, Wp is completely unmethylated. Furthermore, we have analyzed rare LCLs, recently established using wild-type EBV isolates, and rare Burkitt lymphoma (BL) cell clones, recently established from tumors carrying EBNA2-deleted EBV genomes, which express EBNAs exclusively from Wp-initiated transcripts. Here, in sharp contrast to standard LCL and BL lines, all resident copies of Wp appear to be predominantly hypomethylated. Thus, studies of B cells with atypical patterns of Wp usage emphasize the strong correlation between the presence of unmethylated Wp sequences and promoter activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16920819      PMCID: PMC1641762          DOI: 10.1128/JVI.01204-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators.

Authors:  R Feederle; M Kost; M Baumann; A Janz; E Drouet; W Hammerschmidt; H J Delecluse
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

Review 2.  Genomic DNA methylation: the mark and its mediators.

Authors:  Robert J Klose; Adrian P Bird
Journal:  Trends Biochem Sci       Date:  2006-01-05       Impact factor: 13.807

3.  Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays.

Authors:  Andrew I Bell; Katherine Groves; Gemma L Kelly; Debbie Croom-Carter; Edwin Hui; Anthony T C Chan; Alan B Rickinson
Journal:  J Gen Virol       Date:  2006-10       Impact factor: 3.891

4.  Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF.

Authors:  Charles M Chau; Xiao-Yong Zhang; Steven B McMahon; Paul M Lieberman
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

5.  5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael.

Authors:  M G Masucci; B Contreras-Salazar; E Ragnar; K Falk; J Minarovits; I Ernberg; G Klein
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

6.  Differential methylation of Epstein-Barr virus latency promoters facilitates viral persistence in healthy seropositive individuals.

Authors:  E J Paulson; S H Speck
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  The activity of the Epstein-Barr virus BamHI W promoter in B cells is dependent on the binding of CREB/ATF factors.

Authors:  H Kirby; A Rickinson; A Bell
Journal:  J Gen Virol       Date:  2000-04       Impact factor: 3.891

8.  Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.

Authors:  Gemma L Kelly; Anne E Milner; Gouri S Baldwin; Andrew I Bell; Alan B Rickinson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-25       Impact factor: 11.205

9.  Epstein-Barr virus-induced B-cell transformation: quantitating events from virus binding to cell outgrowth.

Authors:  Claire Shannon-Lowe; Gouri Baldwin; Regina Feederle; Andrew Bell; Alan Rickinson; Henri-Jacques Delecluse
Journal:  J Gen Virol       Date:  2005-11       Impact factor: 3.891

10.  Mutually exclusive use of viral promoters in Epstein-Barr virus latently infected lymphocytes.

Authors:  M Woisetschlaeger; J L Strominger; S H Speck
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

View more
  17 in total

1.  The nucleotide polymorphisms within the Epstein-Barr virus C and Q promoters from nasopharyngeal carcinoma affect transcriptional activity in vitro.

Authors:  Feng-Wei Wang; Xian-Rui Wu; Wen-Ju Liu; Ying-Jie Liang; Yu-Fan Huang; Yi-Ji Liao; Chun-Kui Shao; Yong-Sheng Zong; Shi-Juan Mai; Dan Xie
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-07       Impact factor: 2.503

2.  Contributions of CTCF and DNA methyltransferases DNMT1 and DNMT3B to Epstein-Barr virus restricted latency.

Authors:  David J Hughes; Elessa M Marendy; Carol A Dickerson; Kristen D Yetming; Clare E Sample; Jeffery T Sample
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

3.  Chromatin profiling of Epstein-Barr virus latency control region.

Authors:  Latasha Day; Charles M Chau; Michael Nebozhyn; Andrew J Rennekamp; Michael Showe; Paul M Lieberman
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

4.  The members of an Epstein-Barr virus microRNA cluster cooperate to transform B lymphocytes.

Authors:  Regina Feederle; Janina Haar; Katharina Bernhardt; Sarah D Linnstaedt; Helmut Bannert; Helge Lips; Bryan R Cullen; Henri-Jacques Delecluse
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

5.  Autorepression of Epstein-Barr virus nuclear antigen 1 expression by inhibition of pre-mRNA processing.

Authors:  Mikio Yoshioka; Michelle M Crum; Jeffery T Sample
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

6.  Epigenetic and transcriptional changes which follow Epstein-Barr virus infection of germinal center B cells and their relevance to the pathogenesis of Hodgkin's lymphoma.

Authors:  Sarah Leonard; Wenbin Wei; Jennifer Anderton; Martina Vockerodt; Martin Rowe; Paul G Murray; Ciaran B Woodman
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

7.  trans-Repression of protein expression dependent on the Epstein-Barr virus promoter Wp during latency.

Authors:  David J Hughes; Carol A Dickerson; Marie S Shaner; Clare E Sample; Jeffery T Sample
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

8.  Cell cycle association of the retinoblastoma protein Rb and the histone demethylase LSD1 with the Epstein-Barr virus latency promoter Cp.

Authors:  Charles M Chau; Zhong Deng; Hyojueng Kang; Paul M Lieberman
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

Review 9.  Chromatin organization of gammaherpesvirus latent genomes.

Authors:  Italo Tempera; Paul M Lieberman
Journal:  Biochim Biophys Acta       Date:  2009-10-22

10.  An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link.

Authors:  Gemma L Kelly; Heather M Long; Julianna Stylianou; Wendy A Thomas; Alison Leese; Andrew I Bell; Georg W Bornkamm; Josef Mautner; Alan B Rickinson; Martin Rowe
Journal:  PLoS Pathog       Date:  2009-03-13       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.